Publications by authors named "Isabelle Deprez"

Claim this Profile
O
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial.
Lisanne A H Bevers, Gabriela Toledo, Muzamil Kisekka, Elizabeth Kaudha, Grace M Ahimbisibwe, Isabelle Deprez

EBioMedicine· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of the Two-Drug Regimen Dolutegravir-Lamivudine in Adolescents Living With HIV-1 Naive to Antiretroviral Therapy at 48 Weeks (DANCE): A Single-Arm, Open-Label, Phase 3b Trial.
Thanyawee Puthanakit, Linda Aurpibul, Monica Lopez, Marcia Wang, Marika Ciuffa, Isabelle Deprez

J Acquir Immune Defic Syndr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
["Sport contributes to the feeling of confidence and attractiveness, which is fundamental to the ability to acquire leadership"].
Isabelle Deprez, Sonia Guillouët

Rev Infirm· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
Laurent Larifla, Isabelle Déprez, Isabelle Pham, Dominique Rideau, Vanessa Louzier

J Gene Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intratracheal adenoviral vector administration on lung development in newborn rats.
Paul Waszak, Marie-Laure Franco-Montoya, Marie-Paule Jacob, Isabelle Deprez, Micheline Levame

Hum Gene Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.
Sacha Gogev, Nathalie Vanderheijden, Myle'ne Lemaire, Frédéric Schynts, Jean D'Offay, Isabelle Deprez

Vaccine· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis